Recent investigations have revealed that tumor-infiltrating CD8+T cells initially exhibit ITGA2 expression, which subsequently facilitates the repositioning of T cells within the TME and induces CD8+T cell dysfunction (47). The gene discussed is CD8A; the disease is neoplasm.